Tag Archive | "cancer biopathie"

Cancer and Present-Day Human Sexual Functioning: What is the Connection? Part Two


AUTHOR’S NOTE

It will likely come as a shock to many to learn that, in the US today, 1 in 3 women will develop cancer in their lifetime, with 1 in 8 women suffering from breast cancer. And that 1 in 2 men will develop cancer in their lifetime, with 1 in 8 getting prostate cancer.

In 2024, there will be an estimated 1,958,310 new cancer cases in the US (Males 1,010,310; Females 948,000) And there will be an estimated 609,820 new cancer deaths (Males 322,080; Females 287,740) It is predicted that there will be 300,590 new cases of breast cancer (Males 2,800; Females 297,790) and 43,700 breast cancer deaths (Males 530; Females 43,170).

About 414,350 new cases will involve the genital system (Males 299,540; Females 114,810) with new deaths from these cancers reaching 69,660 (Males 35,640; Females 34,020). There are expected to be 288,300 new cases of prostate cancer and 34,700 deaths from that disease in 2024.

It is a significant but little noted fact that about 30% of cancer in men and 40% of cancer in women involves the genital system or breast. This high percentage is much the same today as it was 20 years ago when the following two-part article was written. In light of these facts, the articles below remain relevant and require attention. They are not being published for their histortical interest. Rather, the unanswered questions that are raised in them deserve answers more than ever, answers that can only come from medical research.

“Reich’s theory that cancer is not primarily a tumor that arises mysteriously in an otherwise healthy organism but a systemic disease due to chronic sexual starvation will startle the average person who tends to view a disturbance of sexuality as distressing but not pathogenic. It will also enrage many who, because of moral prejudice, find such a connection offensive and untenable.”
—Chester M. Raphael, MD in his Foreword to The Cancer Biopathy by Wilhelm Reich.

In part one of this article, the 2003 annual statistics published by the American Cancer Society (ACS) were reviewed. The data compiled by the ACS reveal two extremely important facts:

1. Out of 1,334,100 new cases of cancer that will occur in 2003, fully 526,500 will be cancers of the genital system and of the breast; and

2. Out of 556,500 expected cancer deaths, an estimated 96,400 will be from cancers of the genital system and breast

In other words, nearly 40% of all new cancer cases in the United States in 2003 involved either the genital system or the breast in American men and women. And nearly 20% of all cancer deaths were caused by cancers of the breast or genital systems.

Why does cancer occur so frequently in these parts of the body? How is present-day human sexual functioning connected with the high incidence of morbidity and mortality from cancer that our society now experiences?

This article will look at the theory of the origin and nature of cancer put forward by the pioneering physician-scientist Wilhelm Reich in his 1948 book, The Cancer Biopathy. Cancer is one example of a type of disease Reich referred to as a “biopathy.” He wrote, “The term biopathies refers to all disease processes caused by a basic dysfunction of the autonomic life apparatus. Once started, this dysfunction can manifest itself in a variety of symptomatic disease processes.”

For Reich, the biopathic process can lead to cancer in some people, to cardiovascular disease in others, and to catatonic or paranoid schizophrenia in still others. He included some cases of angina pectoris, asthma, epilepsy, anxiety neurosis, multiple sclerosis, chorea and chronic alcoholism as other examples of biopathic disease. The term “biopathy” was used by Reich to describe a patient’s condition only when “it is definite that the disease process begins with a disturbance of pulsation, no matter what secondary disease pattern results.”

To the mechanistic mind, it probably seems inconceivable that such different diseases can be related. What could be the common denominator of all of these diverse conditions? For Reich, it is “a disturbance of the natural function of pulsation in the total organism.” In his view, the organism, in whole and in part, oscillates betweenexpansion and contraction, with biological pulsation being indicative of healthy functioning. The heartbeat is a good example of this biological activity.

Many healing traditions from around the world-such as Ayurveda or Traditional Chinese Medicine-emphasize “balance” as integral to health. These and other healing traditions also refer to “energy” in the body. All of the ancient traditions of medicine, and many of the more recent approaches, such as homeopathy, recognize the existence of a life energy or life force in the organism. And all of these healing techniques emphasize the importance of the movement of the energy in the body for maintaining wellness and curing disease. The movement of energy in the body is believed to bring about a state of “energy balance.” The free movement of this vital energy is the foundation of good health. However, in these traditions, “energy” remains a concept, premise or principle, whether it be spiritual or philosophical.

For Reich, in contrast, the life energy (which he called orgone) is a physical energy that is demonstrable, measurable and usable. (See The Cancer Biopathy, Chapter 4, “The Objective Demonstration of Orgone Energy.”) He, too, recognized that a state of “energy balance” is essential to health. But for him, that “energy balance” comes about through the sexual act. It is the biophysical function of the orgasm to discharge the bioenergy that builds up in the body. Energy builds up in the body, is discharged through the orgasm, keeping the body in “balance.” Sexual dysfunction leads to being “out of balance.” And it can cause, not only emotional distress, but also, physical disease.

To Reich, sexual dysfunction, and the concomitant biological stasis of energy, is the single common denominator underlying the many manifestations of cancer. But the crucial relationship between impaired sexual functioning and energy stasis with diseases such as cancer are not addressed in most other healing traditions. For example, I have attended many excellent seminars on complementary approaches to health, and on integrating complementary and conventional approaches to cancer, and have never heard a single mention of the role of sexual function and dysfunction in health and disease. This was true whether the conference lasted for one-day or for one week.

Reich’s thesis concerning cancer was stated clearly and succinctly in The Cancer Biopathy, “Sexual stasis represents a functional disturbance of biological pulsation. Sexual excitation is a primal function of the living plasma system.The sexual function is demonstrably the productive life function per se. A chronic disturbance of this function must of necessity coincide with a biopathy.”

According to Reich, this disturbance is felt in two principal ways: (1) in an indirect manner as an emotional disturbance (i.e., neurosis or psychosis) or (2) directly as a functional organic disturbance (i.e., a physical disease). In either case, Reich wrote, “The central mechanism of a biopathy is a disturbance in the discharge of biosexual excitation.” Physical, chemical and emotional processes are all at play in biopathic conditions. Emotional factors are involved as well.

Reich’s research focused on elucidating the true nature of the energy expressed in the orgasm. His findings and conclusions are presented in The Discovery of the Orgone: Vol. 1, The Function of the Orgasm and Vol. 2, The Cancer Biopathy. To comprehend Reich’s theory of cancer, it is necessary to understand his findings concerning orgone energy. There are two major obstacles in the way to achieving this: (1) the mechanistic understanding of disease and (2) the incapacity of the average man and woman to perceive the movement of the orgone energy in his or her body.

Reich did not claim that a cure to cancer had been found. “I do not publish this book without serious concern,” he wrote, “mainly that many readers of our literature will now assume that a cure for cancer has been found. This is not at all the case.” In fact, he came to understand that prevention, not cure, is the ultimate solution to cancer. As Dr. Raphael wrote, “The means to this solution are to be found primarily in the social realm, for it is our repressive social order that creates the sexual misery and the resulting stagnation of biological energy from which cancer originates.” It is more obvious than ever that humanity is suffering severely from sexual dysfunction. And cancer incidence and mortality increase dramatically with each passing year.

In the past, Reich’s contribution to an understanding of cancer has been received with either blind rejection or silence. No major attempt has been made over the past 55-60 years to examine Reich’s functional theory of the origin and development of cancer and other biopathic diseases, including treatment possibilities and the potential for disease prevention.

Today, the nature of cancer remains a mystery. Cancer treatment—whether conventional, complementary or integrative—is still largely symptomatic with unpredictable results. Reich remains ignored by the overwhelming majority of conventional, complementary and integrative physicians and health practitioners. This brief two-part article barely skims the surface of Reich’s contribution in this area, providing only an inkling of the wealth of information contained in his book. It is time that fresh, open-minded scrutiny be given to the valuable insights offered by Reich in The Cancer Biopathy. It is needed more than ever.

Disclaimer: This article is copyrighted material that was originally published on 2004 Journal of the Mindshift Institute

Posted in Biopathies & Physical Orgone TherapyComments (2)

Cancer and Present-Day Human Sexual Functioning: What is the Connection? Part One


AUTHOR’S NOTE

It will likely come as a shock to many to learn that, in the US today, 1 in 3 women will develop cancer in their lifetime, with 1 in 8 women suffering from breast cancer. And that 1 in 2 men will develop cancer in their lifetime, with 1 in 8 getting prostate cancer.

In 2024, there will be an estimated 1,958,310 new cancer cases in the US (Males 1,010,310; Females 948,000) And there will be an estimated 609,820 new cancer deaths (Males 322,080; Females 287,740) It is predicted that there will be 300,590 new cases of breast cancer (Males 2,800; Females 297,790) and 43,700 breast cancer deaths (Males 530; Females 43,170).

About 414,350 new cases will involve the genital system (Males 299,540; Females 114,810) with new deaths from these cancers reaching 69,660 (Males 35,640; Females 34,020). There are expected to be 288,300 new cases of prostate cancer and 34,700 deaths from that disease in 2024.

It is a significant but little noted fact that about 30% of cancer in men and 40% of cancer in women involves the genital system or breast. This high percentage is much the same today as it was 20 years ago when the following two-part article was written. In light of these facts, the articles below remain relevant and require attention. They are not being published for their histortical interest. Rather, the unanswered questions that are raised in them deserve answers more than ever, answers that can only come from medical research.

Perhaps the very title of this article is puzzling to many readers. What does the question even mean, many may wonder. “What connection between human sexual functioning and cancer?” some may ask.

In 1999, researchers in the United States reported that between 30-40 percent of American men and women suffered from such severe sexual dysfunction that they had no sexual life and did not desire one. Are there pathological physical consequences to this disturbance of a basic biological function as well as emotional and psychological ones?

Let’s look at the American Cancer Society’s (ACS) 2003 annual cancer statistics, which were published in the January/February 2003 issue of the Society’s publication, Ca-A Cancer Journal for Clinicians, to get a clear picture of cancer incidence and mortality involving the breast and genital system in men and women.

The ACS estimates that in 2003, there will be about 1,334,100 new cancer cases in men and women in the United States. The breakdown by gender is 675,300 new cancer cases among men and 658,800 among women.

The ACS also estimates that there will be 556,500 deaths from cancer in the United States in 2003, of which 285,900 will occur in men and 270,600 in women.

There will be an estimated 212,600 new cases of breast cancer in 2003 (211,300 in women and 1,300 in men) and 313,600 estimated cases of cancers of the genital system (229,000 in men; 83,700 in women).

According to the ACS, 39,800 women will die from breast cancer in 2003 (as will 400 men). A total of 56,300 Americans will die from cancer of the genital system (29,500 men and 26,800 women).

The annual statistics compiled by the ACS reveal two extremely important facts:

1. Out of 1,334,100 new cases of cancer that will occur in 2003, fully 526,500 will be cancers of the genital system and of the breast; and

2. Out of 556,500 expected cancer deaths, an estimated 96,400 will be from cancers of the genital system and breast

In other words, nearly 40% of all new cancer cases in the United States in 2003 will involve either the genital system or the breast in American men and women. And nearly 20% of all cancer deaths will be caused by cancers of the breast or genital systems.

There is no medical research into why this is happening. To me this is astounding, and has been for over one quarter of a century.

I first noticed this correlation in 1977 when I worked for the American Cancer Society on its clinical journal Ca-A Cancer Journal for Clinicians. The percentage of new cancer cases and cancer deaths from these types of cancer has held relatively steady over the last 25 years, no matter what statistical methods the ACS was using at any given time.

I pointed out this statistical finding to fellow editors, physicians, and colleagues in other departments at the ACS. To my great surprise, I discovered that it meant little or nothing to them.

At the time, I sent query letters to editors at professional medical publications, as well as magazines for the public that covered health issues, suggesting that I write an article on the substantial cancer incidence and mortality from breast and genital system cancers and the lack of research into this phenomenon. To my even greater surprise, there was no interest whatsoever in publishing an article on these statistical correlations and the lack of investigation into it.

Interestingly, after I would inform the editors of the large percentage of cancers occurring at these sites, and explain that there was no research into why this was happening, editor after editor would ask, “Where’s the story?” To which I would reply, “The high rates of new cancer cases, the high death rates from the cancers, and the lack of investigation into it — that’s the story!”

During the 1980s and 1990s, I continued to attempt to interest editors, to no avail. Today’s journalists show no more interest. In March 2003, I had an opportunity to discuss this subject with the producer of a major television news show. Even though this intelligent, savvy producer has had cancer, no interest was expressed in reporting the statistical facts or investigating the subject more deeply.

Imagine the uproar and outrage if it were discovered that 40% of new cancers and 20% of cancer deaths each year occurred in the brain or liver or kidneys but that the reasons for this were not being sought. It would not be tolerated by the public or the mass media.

But 525,600 new cancers cases and 96,400 cancer deaths in 2003 alone apparently are not of sufficient interest. Neither is there a desire to explore why there is a complete lack of investigation into the causes of this phenomenon.

The standard responses that “cancer is not one disease, but hundreds of diseases” or “the causes of cancer are multifactorial” or even a blanket response of “there is no connection” do not suffice. Why? Because no research has been done to support such an “explanation.”

So the question stands, “What is the connection between the development of, and death from, cancer of the genital system and of the breast in women and men and present-day human sexual functioning?”

A subsequent article will explore one attempt to answer that question.

Disclaimer: This article is copyrighted material that was originally published on 2003 Journal of the Mindshift Institute

Posted in Biopathies & Physical Orgone TherapyComments (0)

ORGONE BLANKET AS A COMPLEMENTARY SUPPORT IN THE TREATMENT OF AN ATROPHIC-CANCER BIOPATHY


ORGONE BLANKET AS A COMPLEMENTARY SUPPORT IN THE TREATMENT OF AN ATROPHIC-CANCER BIOPATHY.

A CASE REPORT

Tommaso Aprile, Fiorenzo Carlino, Salvatore Del Prete, Isabella Angelone, Antimo Cammisa, Fulvio Cusani, Nicola Dello Iacovo

 

Summary

Results of the treatment of a pancreatic adenocarcinoma with the support of an orgone blanket of the type devised by Wilhelm Reich are reported and discussed.  At eight months from the diagnosis of the disease, the total-body PET CT scan no longer detected any pathological localization.

Introduction

In his book The Cancer Biopathy Reich reported several cases concerning the use of the orgone therapy for the treatment of biopathies (1) in humans, and specifically in atrophic and cancerous ones. In the text it is detailed that large masses of tumor cells dissolved, sometimes so fast that it became a problem, at times lethal, to dispose of the dead tumor cells and T-bacilli (2) through the kidneys, the liver, and the lymphatic system. As a research group,The Campania Felix, we decided to apply Reich’s experiences in consenting patients. We started around two years ago by treating an atrophic-cancerous biopathy, and other biopathies, with an orgone blanket. Being that orgone therapy is not officially recognized in Italy, we used it as a complementary support tool of the official medical therapies prescribed by the National Health Service (SSN).

In this article we report a case that, due to the unusual nature of the results, resembles some of those reported by Reich himself. The diagnoses, clinical examinations, prognoses and therapies were those prescribed and carried out by SSN’s personnel, and were done independently from the activity of our group.

Clinical case

A 67-year old male patient (B. C.) was suffering from diabetes mellitus (treated with Metformin and Lantus), hypercholesterolemia, arterial hypertension, and right bundle branch block. In anamnesis he underwent a proctological intervention for perianal fistula. In February 2017 he reported the appearance of abdominal pain, for which the following exams were performed:

  1. EGDS (esophagus-gastro-duodenumoscopy): an extrinsic compression of the gastric wall.
  2. Echo of the abdomen: lesion of the uncinate pancreatic process of 3-3.5 cm.
  3. Oncological markers: within the limit.
  4. Chest-abdomen CT (March 10, 2017) (see Illustration 1): lesion of 46 x 31 mm to the uncinate process of the pancreas, unclear cleavage plan with the upper mesenteric artery, free venous vessels. Multiple loco-regional and retroperitoneal lymphadenopathies, the longest was of 18 mm in the retro-pancreatic site. No hepatic lesions. Centimetric adenoma at the right adrenal gland.

The patient then went to the Pancreas Institute of the Integrated University of Verona, Italy, on March 21, 2017, in good general conditions. He reported hyporexia from January and steatorrhea in close relationship with meals from a week. The clinical examination revealed a neoformation in the uncinate process of 41×31 mm infiltrating the arterial vessels; and presence of regional adenopathy. Percutaneous biopsy of the lesion was performed on March 30, 2017, with histological diagnosis of agobioptic frustule of adenocarcinoma (see Illustration 2).

On April 09, 2017 he was admitted at the Oncology Division of the Casa Sollievo della Sofferenza of San Giovanni Rotondo, Italy, where on April 11, 2017, he underwent a CT scan with contrast that confirmed the presence of a voluminous expansive formation of the pancreatic uncinate process, max 48 mm. It was indissociable from the horizontal portion of the duodenum which seemed to be at least partly incorporated. The lesion also infiltrated the upper mesenteric artery and licked the upper mesenteric vein. A tenuous thickening of the perilesional mesenteric adipose planes was associated with small scattered lympho-nodal nodules. More voluminous lymphadenopathies were located in celiac sites, up to about 15 mm, and in the hepatoduodenal ligament up to about 20 mm. The remaining pancreatic parenchyma appeared slightly dis-homogeneous with mild ectasia of the Wirsung duct. In the hepatic parenchyma, in the single arterial phase of the study, there were multiple and minuscule hyperdense focal points, with a maximum size of 7-8 mm, of suspected repetitive nature. Substantially unchanged a 20 mm hypodense nodulation in the context of the left adrenal gland.

The neoformation was judged to be inoperable, and a life expectancy of about 30 days was reported to the patient’s family. At this point the patient started using the orgone blanket, which we assembled (see Illustrations 3 and 4), one hour a day the first week, two hours a day the second week, and then for four hours a day.

Chemotherapy with Abraxane and Gemcitabine was administered to the patient as follows.

  • April 12, 2017: 1/1 cycle
  • April 21, 2017: 2/1 cycle
  • April 28, 2017: 3/1 cycle
  • May 19, 2017: 1/2 cycle
  • May 20, 2017: 2/2 cycle
  • June 05, 2017: 3/2 cycle  –  postponed due to diarrhoea
  • June 20, 2017: 1/3 cycle
  • June 28, 2017: 2/3 cycle

On July 11, 2017 the patient had CT performed with contrast. Compared to the previous exam the following was observed in the medical report: "Modest volumetric reduction of the known heteroformed expansive lesion of the pancreatic uncinate process, currently with a maximum diameter of 44 mm and with a more hypodense structure as per contextual necrotic-regressive phenomena. Reduced ectasia of the Wirsung duct upstream of the lesion and intrahepatic bile ducts. Reduced sizes of the lymphadenopathies: in the celiac site where they currently do not exceed the centimetre, and in the hepato-duodenal ligament where currently the largest one measures 1.5 cm. The small focal lengths with enhancement in the arterial phase appear almost completely disappeared from the liver. Left adrenal nodulation unchanged".

Chemotherapy was continued as follows. It should be outlined that the use of the orgone blanket (four hours per day) in this and in the following phase was never discontinued.

  • July 18, 2017: cycle 1/4
  • July 27, 2017: cycle 2/4
  • August 03, 2017: cycle 3/4
  • August 17, 2017: cycle 1/5
  • August 25, 2017: cycle 2/5
  • September 05, 2017: cycle 3/5

The CT scan with contrast was repeated on September 13, 2017 with the following results as reported in the medical notes: "It is observed a further volumetric reduction of the known heteroformed expansive lesion of the pancreatic uncinate process to 38 mm with lower enhancement of vascular structures. The ectasia of the Wirsung upstream is also reduced, while the calibre of the intrahepatic bile ducts and of the hepatocoledoco, currently of modest size, appear to be superimposable. The size of lymphadenopathies in the celiac area is unchanged and currently do not exceed one centimetre. In the liver, no obvious pathological focal lesions. Mild adrenal hypodense nodulation reduced to 17.5 mm. In the pulmonary area, only the presence of a shaded area of ground glass hyper-density of about 10 mm at the upper left lobe was present. Micro-nodulations hypodense against the left lobe of the thyroid".

Chemotherapy was continued as follows.

  • September 21, 2017: cycle 1/6
  • September 28, 2017: cycle 2/6
  • October 05, 2017: cycle 3/6

On October 24, 2017 PET Total Body CT scan  was performed with the following results noted (see Illustrations 5 and 6): "ANOMALIES OF THE TRACER DISTRIBUTION ARE NOT OBSERVED. CONCLUSIONS: PRESENCE OF AREAS OF HYPERACCUMULATION OF THE RADIOPHARMACEUTICAL REFERRABLE TO A RECURRENT ILLNESS AND/OR RECURRING LESIONS IS NOT OBSERVED".

Observations and Conclusions

From the above results it can be observed a very clear improvement in the history of pancreatic cancer that is presently recognized by the scientific literature as one of the most aggressive and dramatic cancer pathologies.

The improvement was clearly evident with the disappearance of both the liver focal points and the pancreatic mass. We did not find in the literature similar results with the use of chemotherapy only, and it is possible that the complementary support of the orgone blanket has been decisive for this resounding healing process.

This can be explained by the observation that the orgone blanket produces, similarly to the accumulator, a concentration of orgone (vital) energy. This is then absorbed by the organism when it comes into contact with it, thus providing a generalized vagotonic effect and an increase of the body temperature. Microscopic observations show a "biological recharge" action on the red blood cells that appear progressively healthier, or more swollen, and characterized by well-defined contours and a characteristic bluish luminescence. In this way, the energetically-charged red blood cells are able to destroy the tumoral cells and the T-bacilli, whose presence was first discovered by Reich. These entities are always present in this type of pathology it appears.

The cancer tumour is only one of the symptom consequences of the decrease of the energetic level of the whole organism (known to Reich as a biopathy). The orgone therapy improves the general energetic state, and can lead to the remission of a large variety of pathologies. It is important to remind readers in this context that a simple Reich test on living blood allows a very early diagnosis of the cancer pathology, thus enabling determining situations of being "at risk" possibly years before the actual tumoral cells can develop. As a research group we are presently planning to perform the Reich blood test on our patients and that will be the subject of our next paper.

References:

  1. A biopathy is a global disturbance of the energy system of an organism which results in illness.
  2. T-Bacilli are a claimed disease causing microscopic vesicle only the size of a few viral particles which Reich found occurred in blood when living tissue breaks down. It has been claimed to be seen with very strong light microscopy (see Reich W, The Cancer Biopathy).

Bibliography

  1. Reich W, The Cancer Biopathy, Orgone Institute Press, New York, 1948
  2. Maglione R, Methods and Procedures in Biophysical Orgonometry, GEDI Gruppo Editoriale, Rome, Italy, 2012
  3. Grupo Espanol de Consenso en Cancer de Pancreas, Recommendations for Diagnosis, Staging and Treatment of Pancreatic Cancer (part I), Med Clin (Barc), 15;134(14):643-55, May 2010
  4. Li D, et al, Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients with Metastatic Pancreas Adenocarcinoma, Clinical Colorectal Cancer, Volume 14, Issue 4, December 2015
  5. De Meo J, The Orgone Accumulator Handbook, Natural Energy Works, Ashland, Usa, 1989
  6. Kavouras J, Heilen Mit Orgonenergie, Turm Verlag, 2005
  7. www.renatopalmieri.com (accessed August 2018)
  8. www.cellulacancerosa.it (accessed August 2018)
  9. www.heliognosis.com (accessed August 2018)

The Campania Felix is an independent research group based in Italy and is consisting of the following components:

  • Tommaso Aprile, oncologist
  • Salvatore Del Prete, orthopaedic surgeon
  • Fiorenzo Carlino, physiatrist and acupuncturist
  • Isabella Angelone, physiotherapist
  • Antimo Cammisa, physiotherapist
  • Fulvio Cusani, physiotherapist
  • Nicola Dello Iacovo, physiotherapist.

For contacts: fulvio.cusani@gmail.com

 

Figure 1 – Chest-abdomen CT scan carried out on March 10, 2017

Figure 2 – Hystological examination carried out on March 30, 2017

Figure 3 – Orgone blanket. Size 80 x 140 cm, weight 3 kg. The blanket is made by 2 external layers of wool; 2 internal layers of steel wool, separated by a layer of polyester. In use it is placed with the metal layer innermost to the patient.

Figure 4 – Section of the orgone blanket with composing materials

Figure 5 – PET total body CT scan carried out on October 24, 2017 – Medical report

Figure 6 – PET total body CT scan carried out on October 24, 2017 – Images

Please Donate

 

If you benefited from this article, please help to preserve and promote Wilhelm Reich’s legacy by donating any amount. Your contribution is tax deductible and will be used to help orgonomy institutes including Wilhelm Reich’s museum and infant trust.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

Donation Total: $5.00

Posted in Biopathies & Physical Orgone TherapyComments (7)


Please Donate

Be part of the progress. Help to preserve and promote Wilhelm Reich’s legacy and his infant trust fund, the best and only hope for peace, health and prosperity of human race. Make financial contributions to promote orgonomy and its institutions. All contributions are tax deductible.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

Donation Total: $5.00

Webinar: The Institute for Orgonomic Science and its Work in Orgonomy


Wilhelm Reich (oil on canvas) by Morton Herskowitz, D.O.

Subscribe Via Email

Enter your email address:

Delivered by FeedBurner

Wilhelm Reich – Founder of Orgone Therapy

Annals of The Institute for Orgonomic Science (December, 2022)

Featured Book: My Cancer & the Orgone Box

Available for purchase via the Magcloud.

Browse our Archives